Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36829303

Low leukemia burden improves blinatumomab efficacy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer
Publication date
2023 May 1
First author
Queudeville M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer. 2023 May 1;129(9):1316-1318. doi: 10.1002/cncr.34666.
    note
    Source null
    related pmid
    36840338
    relationship
    Comment in

Authors and identifiers

  1. name
    Queudeville M
    type
    Author
  2. name
    Stein AS
    type
    Author
  3. name
    Locatelli F
    type
    Author
  4. name
    Ebinger M
    type
    Author
  5. name
    Handgretinger R
    type
    Author
  6. name
    Gökbuget N
    type
    Author
  7. name
    Gore L
    type
    Author
  8. name
    Zeng Y
    type
    Author
  9. name
    Gokani P
    type
    Author
  10. name
    Zugmaier G
    type
    Author
  11. name
    Kantarjian HM
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Queudeville M
    type
    Author
  2. name
    Stein AS
    type
    Author
  3. name
    Locatelli F
    type
    Author
  4. name
    Ebinger M
    type
    Author
  5. name
    Handgretinger R
    type
    Author
  6. name
    Gökbuget N
    type
    Author
  7. name
    Gore L
    type
    Author
  8. name
    Zeng Y
    type
    Author
  9. name
    Gokani P
    type
    Author
  10. name
    Zugmaier G
    type
    Author
  11. name
    Kantarjian HM
    type
    Author
bibliography ids
  1. nci-bib-12310d6fc0ff26cca56ec23e
book metadata
content sha256
0d29f7a7159cf2f6ba6558dc81c734e360bfa2370b0b6bb7132f43dba479884a
document type
citation
dois
  1. 10.1002/cncr.34667
electronic publication date
display
2023 Feb 24
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:36829303
immutable id
pubmed:36829303@0d29f7a7159cf2f6ba6558dc81c734e360bfa2370b0b6bb7132f43dba479884a
journal
abbreviation
Cancer
issn electronic
1097-0142
issn print
0008-543X
issue
9
name
Cancer
nlm unique id
0374236
pages
1384-1393
volume
129
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer. 2023 May 1;129(9):1316-1318. doi: 10.1002/cncr.34666.
    note
    Source null
    related pmid
    36840338
    relationship
    Comment in
outcomes validated
false
pmid
36829303
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
aa3bd1cf7dfbda985f53a312f05c2e993be61fc6c3c3559d071dabb202d5dbd9
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 May 1
precision
day
year
2023
publication types
  1. Journal Article
  2. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36829303/
title
Low leukemia burden improves blinatumomab efficacy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

Preserved source evidence · Not medical advice